In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
an illustration of a cigarette burning and smoke entering lungs
Feature
How Do Cigarettes Cause Cancer?

Everyone knows that cigarettes cause cancer. But what do we know about how they do it?
Giovanna Whitting
For Thyroid Cancers with RET Mutations, FDA Approves Selpercatinib

The FDA has granted full approval to the targeted therapy selpercatinib (Retevmo®) for treating thyroid cancers that have certain changes in a gene called RET. Learn about MSK’s role in the development of this drug and about how patients may benefit.
Joan Massagué
How Cancer Spreads: Four Emerging Insights About Metastasis

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
How MSK Used TIL Therapy To Treat Melanoma in Roberto

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.
Two women wearing blue MSK volunteer jackets walk smiling down a hospital hallway.
What Happens After Cancer Treatment Ends? Three Survivors Share Their Stories

Read honest stories about the challenges of survivorship from cancer survivors — and learn how MSK continues to care for people long after treatment has ended.
Harini Veeraraghavan stands in front of a radiology display
How MSK Doctors Are Using AI To Improve Radiation Treatment

MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
AACR sign
At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions

Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.
Dr. Eileen O'Reilly seen with MSK nurse Tiffany Upshaw.
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer

Learn how a new drug shows great promise for treating pancreatic by targeting the KRAS mutation, which fuels 90% of the disease.
The latest results come from a team of MSK physicians and scientists (from left to right): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio Scaltriti
In the Clinic
Back-to-Back Studies Support the Use of HER2-Targeted Therapies in Multiple Cancers

Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types.
Family of four sitting and smiling for camera.
Metastatic Breast Cancer and Motherhood

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.